Business Context and Reporting Period
Company: PMGC Holdings Inc. (formerly Elevai Labs Inc.)
Filing Type: Form 8-K (Current Report)
Date of Report: April 24, 2025
Reporting Period: Event date April 24, 2025
Business Context: The Company, an emerging growth company incorporated in Nevada, entered into a material definitive agreement to facilitate the sale of its common stock.
Key Financial Metrics
This filing does not report revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on the terms of a new securities offering agreement.
- Offering Capacity: Up to $100,000,000 aggregate offering price.
- Commission Rate: 3.5% of gross proceeds from sales.
- Reimbursement Cap (Initial): Up to $40,000 for legal and travel expenses.
- Reimbursement Cap (Quarterly): Up to $5,000 per quarter thereafter.
Material Changes
The primary material change is the execution of an At-The-Market (ATM) Issuance Sales Agreement with Univest Securities, LLC on April 24, 2025. This agreement supersedes previous limitations by establishing a new framework for selling shares up to the $100 million cap, utilizing a Registration Statement on Form S-3 (No. 333-284505) declared effective on February 7, 2025.
Guidance, Outlook, and Risks
Management Commentary: The Company has established a mechanism to raise capital through "at-the-market" offerings, allowing for flexibility in timing and volume based on market conditions and Transaction Notices.
Risks and Contingencies:
- Sale Uncertainty: The Company explicitly states it cannot provide assurances that the Sales Agent will sell any shares.
- Termination: The agreement may be terminated by the Company with 30 days' written notice or by the Sales Agent at any time in its sole discretion.
- Dilution: Future sales of shares under this agreement will result in dilution to existing shareholders.
- Duration: The agreement remains in effect for 24 months from April 24, 2025, unless terminated earlier.
Investor Verification Checklist
- Verify the current trading price and volume of PMGC Holdings Inc. (ELAB) to assess the potential dilution impact of a $100 million offering.
- Review the full text of the Sales Agreement (Exhibit 10.1) for specific pricing floors or volume limitations not detailed in the summary.
- Confirm the status of the underlying Registration Statement (No. 333-284505) to ensure no subsequent amendments or suspensions have occurred.
- Monitor future filings for "Transaction Notices" which will indicate actual sales activity and pricing parameters.